The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An open-label, multicenter, randomized phase II study of atezolizumab and bevacizumab with Y90 TARE in patients with unresectable hepatocellular carcinoma (HCC).
 
Aiwu Ruth He
Consulting or Advisory Role - Eisai; Genentech/Roche; Merck
Speakers' Bureau - bms; Eisai; Exelixis
Research Funding - Genentech; Merck
 
Filip Banovac
No Relationships to Disclose
 
Renuka V. Iyer
Consulting or Advisory Role - Advanced Accelerator Applications; AstraZeneca; Bayer; Eisai; Exelixis; Ipsen; Lexicon; Merck; Novartis; QED therapeutics; Sandoz; Sun pharma; Tersera
Research Funding - Cleveland BioLabs (Inst); Genentech/Roche (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Michael Petroziello
No Relationships to Disclose
 
Daniel Brown
Consulting or Advisory Role - Bard Medical; Sirtex Medical
Research Funding - Sirtex Medical
 
Laura Williams Goff
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Exelixis; Genentech; Merck; QED Therapeutics
Research Funding - Agios; ASLAN Pharmaceuticals; Basilea; BeiGene; Bristol-Myers Squibb; Merck (Inst)
 
Richard D. Kim
Consulting or Advisory Role - Bayer; Exelixis; Lilly; QED Therapeutics; SERVIER; Taiho Oncology
Speakers' Bureau - Incyte; Lilly
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst)
 
Nainesh Parikh
No Relationships to Disclose
 
Beau Toskich
Stock and Other Ownership Interests - Vivos Therapeutics
Honoraria - Boston Scientific (Inst); BTG (Inst)
Consulting or Advisory Role - AstraZeneca (Inst); Boston Scientific (Inst); Eisai (Inst); Genentech (Inst); Histosonics (Inst); Johnson & Johnson (Inst); Sirtex Medical (Inst)
Research Funding - AstraZeneca (Inst); Boston Scientific (Inst); Genentech (Inst); Johnson and Johnson (Inst)
Travel, Accommodations, Expenses - Boston Scientific (Inst)
 
Kevin Kim
Consulting or Advisory Role - Boston Scientific; Eisai; Genentech; Sirtex Medical
Research Funding - Galil Medical
 
Yixing Jiang
No Relationships to Disclose
 
Suvranu Ganguli
No Relationships to Disclose
 
Matthew H. Kulke
Research Funding - Bristol Myers Squibb (Inst); tersera (Inst)
 
Samantha Ann Armstrong
No Relationships to Disclose
 
Matthew Johnson
Stock and Other Ownership Interests - Endoshape; FluidX
Consulting or Advisory Role - Argon Medical Devices; Boston Scientific; Cook Medical
Research Funding - Argon Medical Devices; Black Swan Health; Boston Scientific
Expert Testimony - Argon Medical Devices
 
Rachna T. Shroff
Consulting or Advisory Role - AstraZeneca; Basilea; Boehringer Ingelheim; Exelixis; Genentech; Incyte; Merck; QED Therapeutics; SERVIER; Taiho Pharmaceutical
Research Funding - Bayer; Bristol-Myers Squibb; Exelixis; Faeth Therapeutics; Immunovaccine; Loxo/Lilly; Merck; Novocure; Nucana; Pieris Pharmaceuticals; QED Therapeutics; Rafael Pharmaceuticals; Seagen; Taiho Pharmaceutical
 
Gregory Woodhead
No Relationships to Disclose